Citi Team Downgrades US Stocks on Recession Risk, Favors China

image

(Bloomberg) — Citigroup Inc. strategists cut their recommendation on US stocks to neutral on the risk of a recession, joining an increasing number of banks in warning of a growth slowdown.

The market is showing “elements of a deflating bubble” with high uncertainty and the lack of reassurance from the Federal Reserve, strategists including Dirk Willer wrote in a May 27 note. “Given that it will likely take time for the Fed to react to equity and growth weakness, we take our long standing US equity overweight back to zero,” they wrote.

The New York-based bank joins BlackRock Inc. and Morgan Stanley in flagging risks stemming from a slowing US economy as the Federal Reserve tightens to curb inflation. But opinion on US equities remains divided, with some Wall Street analysts betting on a rebound in the belief that the odds of recession are overstated.

The S&P 500 Index has slumped 15% this year on growth fears, although the gauge pared losses to head for its first weekly gain since early April. A weakening dollar, less-hawkish Fed commentary and a decent set of corporate earnings have helped lift market sentiment.

Citi Strategists Say Buy the Dip in Stocks on ‘Healthy’ Returns

Meanwhile, Citigroup remains underweight US credit which “trades poorly into recessions,” while shifting its call on US government bonds back to neutral from underweight as a hedge for risky assets.

The bank also maintained its optimistic view on Chinese equities and sovereign bonds, saying it still wants to be exposed to the nation’s assets “with China being the only major market where authorities are at least marginally supportive.”

More Wall Street banks have become sanguine on Chinese stocks recently amid efforts by authorities to shore up economic growth. JPMorgan Chase & Co. analysts upgraded Chinese technology firms to overweight from underweight just two months after deeming the sector “uninvestable”, while UBS Group AG and Credit Suisse Group AG are both bullish on the broader market.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More